Cagent Vascular

United States · Healthtech · Hardware

Develops endovascular serration and lithotripsy technologies for peripheral and coronary artery disease

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series D$41MAstoria Health Investors — Role not disclosedU.S. Venture Partners (USVP) — Role not disclosed
Sourcescagentvascular.com ↗